AFBSX
Price
$22.29
Change
+$0.02 (+0.09%)
Updated
Sep 14 closing price
Net Assets
624.41K
RYIHX
Price
$49.83
Change
+$0.13 (+0.26%)
Updated
Sep 14 closing price
Net Assets
15.38M
Interact to see
Advertisement

AFBSX vs RYIHX

AFBSX vs RYIHX Comparison Chart in %
View a ticker or compare two or three
VS
AFBSX vs. RYIHX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFBSX is a Hold and RYIHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYIHX has more cash in the bank: 15.4M vs. AFBSX (624K). AFBSX (0.00) and RYIHX (0.00) have matching dividends . AFBSX was incepted earlier than RYIHX: AFBSX (21 years) vs RYIHX (19 years). AFBSX (6.34) is less costly to investors than RYIHX (1.66). RYIHX has a lower initial minimum investment than AFBSX: RYIHX (2500) vs AFBSX (15000). AFBSX IRA initial investment is lower compared to RYIHX: AFBSX (15000) vs RYIHX (1000). RYIHX annual gain was more profitable for investors over the last year : 3.84 vs. AFBSX (-2.71). RYIHX return over 5 years is better than : 4.26 vs. AFBSX (-12.22).
AFBSXRYIHXAFBSX / RYIHX
Total Expense Ratio2.781.58176%
Annual Report Gross Expense Ratio6.341.66382%
Fund Existence21 years19 years-
Gain YTD-1.4174.127-34%
Front LoadN/AN/A-
Min. Initial Investment150002500600%
Min. Initial Investment IRA1500010001,500%
Net Assets624K15.4M4%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.713.84-70%
Returns for 3 years-16.22-4.73342%
Returns for 5 years-12.224.26-287%
Returns for 10 years-39.73-22.49177%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLRHX27.020.31
+1.16%
Nomura Healthcare Fund Class R
LGLOX60.26N/A
N/A
Lord Abbett Growth Leaders F3
STCAX18.53N/A
N/A
Virtus Silvant Large-Cap Growth Stk I
LMOPX48.62N/A
N/A
Patient Opportunity C
POIRX14.40N/A
N/A
Polen International Growth Investor